Literature DB >> 17704346

Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes.

Maciej T Malecki1, Anetta Undas, Katarzyna Cyganek, Barbara Mirkiewicz-Sieradzka, Pawel Wolkow, Grzegorz Osmenda, Malgorzata Walus-Miarka, Tomasz J Guzik, Jacek Sieradzki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17704346     DOI： 10.2337/dc07-1138

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  17 in total

Review 1.  Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.

Authors:  Hiroyuki Konya; Masayuki Miuchi; Kahori Satani; Satoshi Matsutani; Yuzo Yano; Taku Tsunoda; Takashi Ikawa; Toshihiro Matsuo; Fumihiro Ochi; Yoshiki Kusunoki; Masaru Tokuda; Tomoyuki Katsuno; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  World J Exp Med       Date:  2015-05-20

2.  Association between retinol binding protein 4 and diabetic retinopathy among type 2 diabetic patients: a meta-analysis.

Authors:  Wentao Han; Huagen Wei; Weizheng Kong; Jing Wang; Luqian Yang; Huiqun Wu
Journal:  Acta Diabetol       Date:  2020-05-13       Impact factor: 4.280

3.  Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.

Authors:  Sotoodeh Abhary; Kathryn P Burdon; Abraham Kuot; Shahrbanou Javadiyan; Malcolm J Whiting; Nicholas Kasmeridis; Nikolai Petrovsky; Jamie E Craig
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

4.  Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus.

Authors:  W Xia; Y Shao; Y Wang; X Wang; Y Chi
Journal:  J Endocrinol Invest       Date:  2012-10       Impact factor: 4.256

5.  ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes.

Authors:  Radosław Wieczór; Anna M Wieczór; Arleta Kulwas; Danuta Rość
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

Review 6.  Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms.

Authors:  Daniel Gonzalez Izundegui; Matthew Nayor
Journal:  Curr Diab Rep       Date:  2022-02-03       Impact factor: 4.810

7.  Renal function but not asymmetric dimethylarginine is independently associated with retinopathy in type 2 diabetes.

Authors:  Katarzyna Krzyzanowska; Friedrich Mittermayer; Gerit H Schernthaner; Simon Brunner; Johanna M Brix; Stefan Aschauer; Florian Höllerl; Michael Wolzt; Guntram Schernthaner
Journal:  Cardiol Res Pract       Date:  2011-05-09       Impact factor: 1.866

8.  Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines.

Authors:  Sotoodeh Abhary; Nicholas Kasmeridis; Kathryn P Burdon; Abraham Kuot; Malcolm J Whiting; Wai Ping Yew; Nikolai Petrovsky; Jamie E Craig
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 19.112

9.  Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers.

Authors:  You-Lin Tain; Wen-Chin Lee; Chien-Ning Hsu; Wei-Chia Lee; Li-Tung Huang; Chien-Te Lee; Ching-Yuang Lin
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients.

Authors:  Angela Sciacqua; Nadia Grillo; Michele Quero; Giorgio Sesti; Francesco Perticone
Journal:  Int J Mol Sci       Date:  2012-10-24       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.